# Q8(R2) Pharmaceutical Development - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q8r2-pharmaceutical-development/952b87d6-d764-4049-94ad-25d668f24c35

> FDA guidance document: Q8(R2) Pharmaceutical Development. Issue date: November 20, 2009. Get complete insights and analysis.

---

## Details

- Title: Q8(R2) Pharmaceutical Development
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2009-11-20
- Last Changed: 2020-04-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2005-D-0154">FDA-2005-D-0154</a>

## Related Documents

- [E2F Development Safety Update Report](https://www.globalkeysolutions.net/guidances/guidance-document/e2f-development-safety-update-report/fce1434f-a2f0-418e-adf4-9803cbc032bd)
- [S9 Nonclinical Evaluation for Anticancer Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s9-nonclinical-evaluation-for-anticancer-pharmaceuticals/0d1f71ec-dd43-4c57-befe-2d7eb7e145f2)
- [Q11 Development and Manufacture of Drug Substances](https://www.globalkeysolutions.net/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)